Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Flavin mononucleotide-dependent enzymes are a class of oxidoreductases that utilize flavin mononucleotide (FMN) as a prosthetic group or cofactor to catalyze redox reactions. FMN, also known as riboflavin-5′-phosphate, is derived from riboflavin (vitamin B2). These enzymes play essential roles in cellular metabolism and are involved in various physiological processes. FMN acts as an electron carrier, cycling between oxidized (FMN), semiquinone (FMNH•), and reduced (FMNH₂) states during catalysis. They can participate in both one-electron and two-electron transfer reactions. Examples include NADH dehydrogenase and lactate oxidase. They are crucial for energy production, fatty acid oxidation, amino acid metabolism, and cellular defense against oxidative stress. Deficiency or dysfunction can lead to metabolic disorders, and differences in biosynthetic pathways in pathogens present opportunities for drug targeting.
Inhibition of enzymatic activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Flavin Mononucleotide-Dependent Enzyme.